The administration of G-CSF should follow specific guidelines to ensure its effectiveness and safety. It is typically given as a subcutaneous injection, and the dosage may vary depending on the patient's condition and treatment regimen. The American Society of Clinical Oncology (ASCO) and other professional bodies provide detailed guidelines on when and how to use G-CSF in cancer care.